(Q38689437)

5 September 2017

1 reference

title

Drug delivery systems. 1. site-specific drug delivery using liposomes as carriers (English)

1 reference

5 September 2017

1 reference

Ranade VV

1

1 reference

5 September 2017

publication date

1 August 1989

1 reference

The Journal of Clinical Pharmacology

5 September 2017

published in

1 reference

5 September 2017

volume

29

1 reference

5 September 2017

issue

8

1 reference

5 September 2017

page(s)

685-694

1 reference

Protection of guinea pigs against local and systemic foot-and-mouth disease after administration of synthetic lipid amine (Avridine) liposomes.

5 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1989.TB03403.X

The involvement of the lipid phase transition in the plasma-induced dissolution of multilamellar phosphatidylcholine vesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1989.TB03403.X

Fusion of Sendai virions with phosphatidylcholine-cholesterol liposomes reflects the viral activity required for fusion with biological membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1989.TB03403.X

Comparative properties and methods of preparation of lipid vesicles (liposomes).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1989.TB03403.X

Interaction of liposomes with hepatocytes and Kupffer cells in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1989.TB03403.X

pH-sensitive liposomes mediate cytoplasmic delivery of encapsulated macromolecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1989.TB03403.X

Antibody-mediated targeting of liposomes to red cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1989.TB03403.X

Immunoglobulins as targeting agents for liposome encapsulated drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1989.TB03403.X

Monoclonal antibody and liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1989.TB03403.X

Superior therapeutic activity of liposome-associated adriamycin in a murine metastatic tumour model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1989.TB03403.X

Liposomes and local hyperthermia: selective delivery of methotrexate to heated tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1989.TB03403.X

Perspectives in cancer research. Increased selectivity of drugs by linking to carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1989.TB03403.X

21 January 2018

New aspects of liposomes

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1989.TB03403.X

Liposomes in therapeutic and preventive medicine: the development of the drug-carrier concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1989.TB03403.X

Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1989.TB03403.X

Eradication of spontaneous metastases and activation of alveolar macrophages by intravenous injection of liposomes containing muramyl dipeptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1989.TB03403.X

Fate of a liposome-associated agent injected into normal and tumour-bearing rodents. Attempts to improve localization in tumour tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1989.TB03403.X

Intrahepatic uptake and processing of intravenously injected small unilamellar phospholipid vesicles in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1989.TB03403.X

The in vivo transformation of phospholipid vesicles to a particle resembling HDL in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1989.TB03403.X

Disintegration of phosphatidylcholine liposomes in plasma as a result of interaction with high-density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1989.TB03403.X

Liposomes as drug carriers in cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1989.TB03403.X

Therapy of leishmaniasis: Superior efficacies of liposome-encapsulated drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1989.TB03403.X

The use of Pentostam liposomes in the chemotherapy of experimental leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1989.TB03403.X

Antileishmanial activity of antimonials entrapped in liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1989.TB03403.X

Cortisol palmitate liposomes: enhanced anti-inflammatory effect in rats compared with free cortisol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1989.TB03403.X

Artificial surfactant therapy in hyaline-membrane disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1989.TB03403.X

10.1002/J.1552-4604.1989.TB03403.X

21 January 2018

Identifiers

DOI

1 reference

5 September 2017

1 reference